| NCT Number | NCT07612813 |
| Lead Sponsor | AstraZeneca
Collaborators: Parexel |
| Conditions | Staphylococcus Aureus Bloodstream Infection |
| Enrollment | 18 participants |
| Start Date | 2026-06-29 |
| Primary Completion | 2027-09-13 (estimated) |
| Study Completion | 2027-09-13 (estimated) |
| Updated on ClinicalTrials.gov | 2026-07-14 |